Q-1802

· QureBio Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Q-1802, covering 2023-07-28 to 2023-07-28. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors [Phase 1, Phase 2]